Maximize Your Impact At BioPharma Expo 2025
BioPharma Expo 2025, taking place July 9 at Tokyo Big Sight in Koto City, Tokyo, is a focal point for innovation across pharmaceutical development, biotechnology, and life sciences. It brings together regulatory leaders, R&D executives, manufacturing providers, and procurement specialists to evaluate solutions that will move the drug development pipeline forward.
This expo is particularly impactful for companies looking to position themselves in the Japanese and Asia-Pacific life sciences sectors. Attendees include heads of clinical development, C-level executives from biopharma companies, and government health policy makers exploring partnerships, supply chain agreements, and vendor relationships. Key purchasing decisions across laboratory equipment, drug delivery systems, and tech platforms are set in motion here.
With access to Vendelux’s enriched attendee list, your team can gain early insight into the executives driving those decisions. Segmenting by company size and leadership roles allows teams to prioritize outreach ahead of the event and build credibility before setting foot on-site.
How Sales, Marketing and Revops Teams Can Use This Attendee List
BioPharma Expo 2025 draws a high concentration of technical buyers and regulatory-aware executives who make or influence budget decisions. Sales teams can use the attendee data to identify leads involved in procurement cycles for research equipment, supply partners, and compliance solutions. Marketing can organize segmented campaigns with messaging matched to specific product pipelines or research goals.
By leveraging the enriched conference attendee list, teams can book qualified meetings well before the event. Profiles detail job functions and healthcare affiliations, helping your outreach connect with the person most likely to engage. Once on the ground at Tokyo Big Sight, your team can strengthen face-to-face conversations and follow up using targeted information they’ve already gathered—turning booth visits into strategic partnerships.
Knowing how to get more meetings is key, and enriched attendee list insights provide that edge. Companies can tailor calls to action in post-event communication based on whether someone leads R&D, heads quality systems, or manages vendor selection.
Timing Is Everything
BioPharma Expo 2025 is scheduled for July 9, 2025. With major pharma brands and high-growth biotech firms attending, the window for engagement is short but highly valuable.
Using Vendelux, teams get early access to enriched data, allowing them to prioritize high-interest accounts months in advance. Outreach done in May and June translates to meaningful conversations on-site. Match your company’s key messages with attendee goals, and plan interactions that feel timely and informed.
Aligning marketing sequences, outbound messaging, and pre-scheduled demos with attendee profiles can make this one-day event drive an entire quarter’s pipeline.
What’s Included In The BioPharma Expo 2025 Attendee List?
Vendelux provides visibility into executives expected to attend BioPharma Expo 2025 through a combination of organizer-sourced data and predictive analysis. Clients can upload a list of target accounts to surface matches within the attendee base.
The enriched attendee list contains first and last name, job title, company name, company website, location by city, state, and country, LinkedIn profile, verified email address, and phone number when available.
Where Is BioPharma Expo 2025?
Tokyo Big Sight | Koto City, Tokyo, Japan.
When Is BioPharma Expo 2025?
July 9, 2025.
What Type Of Event Is BioPharma Expo 2025?
BioPharma Expo 2025 is a life sciences and pharmaceutical industry trade event focused on R&D solutions, biotechnology innovation, drug manufacturing technologies, and regulatory compliance. It includes keynote presentations, product launches, technical sessions, and direct vendor-buyer meetings.
How Many People Attend BioPharma Expo 2025?
The event is expected to host over 27,000 attendees from across the Asia-Pacific and global markets. Participants include senior leaders such as heads of research, clinical operations directors, purchasing executives, and innovation team leads from pharmaceutical companies and biotech firms.
